ConductScience.org, home

Paper38680717

Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?

Goze H and 3 others. Int J Hematol Oncol Stem Cell Res, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis? Papers, record 38680717. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38680717

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis?
PubMed
Journal
Int J Hematol Oncol Stem Cell Res
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2024-04-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goze HHasan
2Cinli TATahir Alper
3Baydilli KNKursad Nuri
4Serin IIstemi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118924115Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.Hematol Oncol2009https://conductscience.org/library/papers/18924115PubMed
222360654Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.Br J Haematol2012https://conductscience.org/library/papers/22360654PubMed
311255273Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease.Haematologica2001https://conductscience.org/library/papers/11255273PubMed
432384177Hodgkin lymphoma: A 2020 update on diagnosis, risk-stratification, and management.Am J Hematol2020https://conductscience.org/library/papers/32384177PubMed
524202395Microenvironmental regulation of tumor progression and metastasis.Nat Med2013https://conductscience.org/library/papers/24202395PubMed
623161719Prognostic significance of the ratio of absolute neutrophil count to absolute lymphocyte count in classic Hodgkin lymphoma.Am J Clin Pathol2012https://conductscience.org/library/papers/23161719PubMed
725113753Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.J Clin Oncol2014https://conductscience.org/library/papers/25113753PubMed
831864143Diffusion-weighted MRI for initial staging in Hodgkin`s lymphoma: comparison with FDG PET.Eur J Radiol2020https://conductscience.org/library/papers/31864143PubMed
918332908The relationship between absolute lymphocyte count with PFS in patients with Hodgkin's lymphoma undergoing autologous hematopoietic cell transplant.Bone Marrow Transplant2008https://conductscience.org/library/papers/18332908PubMed
109819449A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.N Engl J Med1998https://conductscience.org/library/papers/9819449PubMed
1121993683Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma.Haematologica2012https://conductscience.org/library/papers/21993683PubMed
1232502987Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2020https://conductscience.org/library/papers/32502987PubMed
1320220182Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.N Engl J Med2010https://conductscience.org/library/papers/20220182PubMed
1427607161Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.Clin Nucl Med2017https://conductscience.org/library/papers/27607161PubMed
1526046410Absolute Monocyte Count and Lymphocyte-Monocyte Ratio Predict Outcome in Nodular Sclerosis Hodgkin Lymphoma: Evaluation Based on Data From 1450 Patients.Mayo Clin Proc2015https://conductscience.org/library/papers/26046410PubMed
1624357794The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma.Br J Cancer2014https://conductscience.org/library/papers/24357794PubMed
1730739242Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study.Clin Transl Oncol2019https://conductscience.org/library/papers/30739242PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38680717

GET https://conductscience.org/api/papers/v1/38680717/authors